Welcome to the special meeting of stockholders of Bionano Genomics Inc. I will now hand it over to Erik Holmlin. Thank you, and good morning. I am Erik Holmlin, President, CEO, and Director of Bionano Genomics, Inc, and I will be presiding as Chair of this meeting. I'm very happy to welcome you to Bionano's 2025 special meeting of stockholders. Before I call the meeting to order, I would like to introduce those who are with us here today. Since the meeting is being held virtually via live webcast, we have stockholders attending via web portal. Additionally, Jonathan Dixon, our General Counsel, is in attendance today, and we also have with us present Sue Lianne Lu and Alexander Gefter of Cooley LLP, Bionano's outside counsel, who are available to respond to appropriate questions. The meeting will now officially come to order. We will proceed with the formal business of the meeting as set forth in the Notice of Special Meeting and Proxy Statement. After the formal part of our meeting, we will give you an opportunity to ask any questions. Jonathan Dixon is acting as Secretary of the meeting, and he will now report with respect to the mailing of the Notice of the Meeting and the stockholders' list. I have at this meeting a complete list of stockholders of record of our common stock on November 21, 2024, the record date for this meeting. I also have an affidavit certifying that on December 5th, 2024, a Notice of Special Meeting was deposited in the United States Mail to all stockholders of record as of the close of business on November 21, 2024. Jonathan Dixon has been appointed to act as Inspector of Election at this meeting. Jonathan has taken and subscribed the customary oath of office to execute these duties with strict impartiality. We will file this oath with the records of the meeting. The inspector's function is to decide upon the qualifications of voters, accept their votes, and when balloting on the two matters being voted on is completed to tally the final votes. Jonathan will now report with respect to the existence of a quorum. A preliminary count of the stock represented in person or by proxy at this meeting indicates that the holders of approximately 41% of the outstanding shares of common stock entitled to vote at the meeting are present in person by virtual attendance or by proxy. This constitutes a quorum for the meeting today, and we may now carry out the official business of the meeting. We will now proceed with the formal business of the meeting. There are two proposals to be considered by stockholders at this meeting. The time is now 10:03 A.M. Pacific Time on Wednesday, January 15th, 2025, and the polls are now open for voting on the two matters to be presented. The polls will be closed to voting after we go through the two matters to be voted on. The rules of conduct for the meeting are posted on the Special Meeting portal. We ask that you follow these rules. We will address questions during the Q&A portion of the meeting. If you have a question, please submit it by entering it into the Ask a Question text box in the Special Meeting portal. The first item of business is the proposal to approve, for purposes of complying with Nasdaq Listing Rule 5635(b), the issuance of up to an aggregate of 19,762,226 shares of common stock upon the exercise of certain Series C and Series D warrants issued in connection with a private placement pursuant to the securities purchase agreement dated October 30th, 2024, between the company and certain institutional investors party thereto. We will refer to this proposal as the Share Issuance Proposal. You can find more information regarding this proposal in the Proxy Statement. Are there any questions? The second item of business is the approval of a series of alternate amendments to the company's Amended and Restated Certificate of Incorporation as amended to effect, at the option of the company's Board of a reverse stock split of the company's common stock at a ratio between 1-for-25 and 1-for-75 inclusive, as determined by the company's Board of Directors in its sole discretion. We will refer to this proposal as the Reverse Stock Split Proposal. You can find more information regarding this proposal in the Proxy Statement. Are there any questions? Voting is by proxy and online ballot. You do not need to do anything if you have already sent in your signed proxy, previously voted online, or by telephone, or if you have submitted your proxy or voted online at this meeting. If you have not voted and would like to vote now, or if you would like to change your vote, click the Vote Here button in the special meeting portal and follow the instructions. We'll pause for a moment to give anyone who hasn't yet voted a chance to vote. Each share of our common stock is entitled to one vote. The time is now 10:07 A.M. Pacific Time, and the polls are now closed for voting. The report of the Inspector of Election covering the proposal presented at this meeting is as follows: The Share Issuance Proposal has been approved, the reverse stock split proposal has been approved. We expect to report our final voting results on a current report on Form 8-K to be filed with the SEC within four business days after the end of this meeting. This concludes the formal portion of today's meeting. We will now entertain questions from stockholders. If you have any questions relevant to either of the two matters presented, please enter them into the web portal now. As we have not received any questions from stockholders related to the two matters being presented, we will end the call now. Questions relating to the ongoing business of Bionano may be addressed during upcoming updates that the company provides on a periodic basis. Thank you for attending today's special meeting of stockholders. The meeting is now adjourned. The meeting has now concluded. Thank you for joining. You may now disconnect.